{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T15:41:04Z","timestamp":1762184464114,"version":"build-2065373602"},"reference-count":46,"publisher":"Informa UK Limited","issue":"12","license":[{"start":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T00:00:00Z","timestamp":1693785600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020124","name":"Seagen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020124","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncol."],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.2217\/fon-2023-0358","type":"journal-article","created":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T09:59:41Z","timestamp":1693821581000},"page":"749-760","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Physician frontline treatment preferences for stage III\/IV classic Hodgkin lymphoma: the real-world US CONNECT study"],"prefix":"10.1080","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6900-1824","authenticated-orcid":false,"given":"Andrew M","family":"Evens","sequence":"first","affiliation":[{"name":"Rutgers Cancer Institute of New Jersey","place":["New Brunswick, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8057-9897","authenticated-orcid":false,"given":"Kristina S","family":"Yu","sequence":"additional","affiliation":[{"name":"Seagen Inc.","place":["Bothell, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2468-9482","authenticated-orcid":false,"given":"Nicholas","family":"Liu","sequence":"additional","affiliation":[{"name":"Seagen Inc.","place":["Bothell, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0743-7219","authenticated-orcid":false,"given":"Andy","family":"Surinach","sequence":"additional","affiliation":[{"name":"Genesis Research","place":["Hoboken, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5362-1853","authenticated-orcid":false,"given":"Katherine","family":"Holmes","sequence":"additional","affiliation":[{"name":"Ipsos Healthcare","place":["New York, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0574-4258","authenticated-orcid":false,"given":"Carlos","family":"Flores","sequence":"additional","affiliation":[{"name":"Genesis Research","place":["Hoboken, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3880-0866","authenticated-orcid":false,"given":"Michelle A","family":"Fanale","sequence":"additional","affiliation":[{"name":"Seagen Inc.","place":["Bothell, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3914-9534","authenticated-orcid":false,"given":"Darcy R","family":"Flora","sequence":"additional","affiliation":[{"name":"Gryt Health","place":["Rochester, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0282-6490","authenticated-orcid":false,"given":"Susan K","family":"Parsons","sequence":"additional","affiliation":[{"name":"Tufts Medical Center","place":["Boston, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2023,9,4]]},"reference":[{"key":"e_1_3_9_3_1","unstructured":"National Institutes of Health . Cancer stat facts: Hodgkin lymphoma. https:\/\/seer.cancer.gov\/statfacts\/html\/hodg.html (12 August 2022)."},{"key":"e_1_3_9_4_1","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/920898"},{"key":"e_1_3_9_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199211193272102"},{"key":"e_1_3_9_6_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.64.5648"},{"key":"e_1_3_9_7_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.43.4803"},{"key":"e_1_3_9_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30500-X"},{"key":"e_1_3_9_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.3298"},{"key":"e_1_3_9_10_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.44.3721"},{"key":"e_1_3_9_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30215-7"},{"key":"e_1_3_9_12_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-01-778548"},{"issue":"2","key":"e_1_3_9_13_1","article-title":"Incidence and predictors of pulmonary events among patients with Hodgkin lymphoma treated with bleomycin in the US Department of Defense Healthcare System","volume":"7","author":"Fox KM","year":"2018","unstructured":"Fox KM , FelicianoJ , AlzolaC , EvansA , MorrisT. Incidence and predictors of pulmonary events among patients with Hodgkin lymphoma treated with bleomycin in the US Department of Defense Healthcare System. Chemotherapy: Open Access7(2), (2018).","journal-title":"Chemotherapy: Open Access"},{"issue":"3","key":"e_1_3_9_14_1","first-page":"466","article-title":"Pulmonary toxicity following bleomycin use: a single-center experience","volume":"13","author":"Madabhavi I","year":"2017","unstructured":"Madabhavi I , ModiG , PatelA , AnandA , PanchalH , ParikhS. Pulmonary toxicity following bleomycin use: a single-center experience. J. Cancer Res. Ther.13(3), 466\u2013470 (2017).","journal-title":"J. Cancer Res. Ther."},{"key":"e_1_3_9_15_1","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/480608"},{"key":"e_1_3_9_16_1","doi-asserted-by":"publisher","DOI":"10.1177\/1179554917731072"},{"key":"e_1_3_9_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25071"},{"key":"e_1_3_9_18_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2013.103218"},{"key":"e_1_3_9_19_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1510093"},{"key":"e_1_3_9_20_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.63.1119"},{"key":"e_1_3_9_21_1","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2018.1.200"},{"key":"e_1_3_9_22_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000719"},{"key":"e_1_3_9_23_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2020.0026"},{"key":"e_1_3_9_24_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17051783"},{"key":"e_1_3_9_25_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.19.8820"},{"issue":"5","key":"e_1_3_9_26_1","first-page":"CD007941","article-title":"Comparison of first-line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with early unfavourable or advanced stage Hodgkin lymphoma","volume":"5","author":"Skoetz N","year":"2017","unstructured":"Skoetz N , WillA , MonsefI , BrillantC , EngertA , Von TresckowB. Comparison of first-line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with early unfavourable or advanced stage Hodgkin lymphoma. Cochrane Database Syst. Rev.5(5), CD007941 (2017).","journal-title":"Cochrane Database Syst. Rev."},{"key":"e_1_3_9_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32134-7"},{"key":"e_1_3_9_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(21)00101-0"},{"key":"e_1_3_9_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15566"},{"key":"e_1_3_9_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.3891"},{"key":"e_1_3_9_31_1","unstructured":"U.S. Census Bureau . Census regions and divisions of the United States. www2.census.gov\/geo\/pdfs\/maps-data\/maps\/reference\/us_regdiv.pdf (12 July 2023)."},{"key":"e_1_3_9_32_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2206125"},{"key":"e_1_3_9_33_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2023.2193854"},{"key":"e_1_3_9_34_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.79.0139"},{"key":"e_1_3_9_35_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.53.5229"},{"key":"e_1_3_9_36_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2022.0021"},{"key":"e_1_3_9_37_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.54.8800"},{"key":"e_1_3_9_38_1","doi-asserted-by":"publisher","DOI":"10.1200\/OP.22.00811"},{"key":"e_1_3_9_39_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-140698"},{"key":"e_1_3_9_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2023.03.015"},{"key":"e_1_3_9_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2021.12.012"},{"key":"e_1_3_9_42_1","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2018.1542599"},{"key":"e_1_3_9_43_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.00122"},{"key":"e_1_3_9_44_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2022-162573"},{"key":"e_1_3_9_45_1","doi-asserted-by":"publisher","DOI":"10.2147\/CEOR.S178649"},{"key":"e_1_3_9_46_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2022-162603"},{"key":"e_1_3_9_47_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-152497"},{"key":"e_1_3_9_48_1","volume-title":"Pan Pacific Lymphoma Conference.","author":"Evens AM","year":"2022","unstructured":"Evens AM , YuKS , LiuNet al. Classic Hodgkin lymphoma: real-world observations from physicians, patients, and caregivers on the disease and its treatment (CONNECT): physician frontline treatment preferences for stage III or IV Classic Hodgkin lymphoma. Presented at: Pan Pacific Lymphoma Conference.Koloa, HI (2022)."}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fon-2023-0358","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T14:56:53Z","timestamp":1762181813000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fon-2023-0358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,4]]},"references-count":46,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["10.2217\/fon-2023-0358"],"URL":"https:\/\/doi.org\/10.2217\/fon-2023-0358","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"type":"print","value":"1479-6694"},{"type":"electronic","value":"1744-8301"}],"subject":[],"published":{"date-parts":[[2023,9,4]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-04-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}